InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
9
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Constantino Michael T., Directeur. Officer active across 2 companies, notably 9 METERS BIOPHARMA, INC.. In total, 10 disclosures have been recorded. Split: 9 buys · 0 sell. Total volume traded: €126k. History available since 24 August 2021. The latest transaction was disclosed on 7 April 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Constantino Michael T.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
16,000 shares@ US$1.2621.3% of flowCommon StockSEC:0001818382-25-000044:0
Canonical exit: 6 Jul 2025 (T+90)
4,600 shares@ US$4.387222.1% of flowCommon StockSEC:0001818382-24-000216:0
Canonical exit: 4 Mar 2025 (T+90)
3,100 shares@ US$6.288320.5% of flowCommon StockSEC:0001818382-24-000158:0
Canonical exit: 13 Nov 2024 (T+90)
4,750 shares@ US$4.1821.2% of flowCommon StockSEC:0001818382-23-000032:0
Canonical exit: 16 Aug 2023 (T+90)
7,885 sharesCommon StockSEC:0001578563-23-000011:0
16,000 shares@ US$0.475529.0% of flowCommon StockSEC:0001578563-22-000018:0
Canonical exit: 21 Aug 2022 (T+90)
2,000 shares@ US$4.8310.7% of flowCommon StockSEC:0001818382-22-000047:0
Canonical exit: 21 Aug 2022 (T+90)
26,508.74 shares@ US$0.754528.6% of flowCommon stockSEC:0001551986-22-000025:0
Canonical exit: 18 Nov 2020 (T+90)
200 shares@ US$10.832.3% of flowCommon StockSEC:0001104659-21-143251:0
Canonical exit: 20 Feb 2022 (T+90)
18,000 shares@ US$1.1471.0% of flowCommon stockSEC:0001551986-21-000099:0
Canonical exit: 22 Nov 2021 (T+90)
10 of 10 declarations
About Constantino Michael T.
Constantino Michael T. is Director at Humacyte, Inc. and 9 METERS BIOPHARMA, INC. He has 10 filings in total, and across the 10 sampled filings, buys amount to EUR 126252, with no sells, between 2021-08-26 and 2025-04-08. The largest transactions involve Humacyte, Inc. on 2024-12-04 for EUR 19200.31764124341, on 2025-04-08 for EUR 18469.38347959241, on 2023-05-19 for EUR 18426.23554799625, and on 2024-08-15 for EUR 17765.61156985615, as well as 9 METERS BIOPHARMA, INC. on 2021-08-26 for EUR 17459.23568708562 and on 2022-03-21 for EUR 16844.70653554413.
